Dapsone is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Mayne Pharma Inc.. The primary component is Dapsone.
Product ID | 68308-342_c83080e3-9998-4734-914b-594f7fd84482 |
NDC | 68308-342 |
Product Type | Human Prescription Drug |
Proprietary Name | Dapsone |
Generic Name | Dapsone |
Dosage Form | Gel |
Route of Administration | TOPICAL |
Marketing Start Date | 2022-02-11 |
Marketing Category | ANDA / |
Application Number | ANDA214722 |
Labeler Name | Mayne Pharma Inc. |
Substance Name | DAPSONE |
Active Ingredient Strength | 75 mg/g |
Pharm Classes | Sulfone [EPC], Sulfones [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-02-11 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0378-4830 | Dapsone | Dapsone |
0904-7018 | DAPSONE | Dapsone |
0904-7019 | DAPSONE | Dapsone |
10135-654 | DAPSONE | Dapsone |
10135-655 | DAPSONE | Dapsone |
13668-605 | dapsone | dapsone |
13925-504 | Dapsone | Dapsone |
13925-505 | Dapsone | Dapsone |
16714-956 | Dapsone | Dapsone |
29033-036 | Dapsone | Dapsone |
29033-037 | Dapsone | Dapsone |
42291-298 | Dapsone | Dapsone |
42291-299 | Dapsone | Dapsone |
43353-222 | Dapsone | Dapsone |
43353-223 | Dapsone | Dapsone |
47781-333 | Dapsone | dapsone |
47781-334 | Dapsone | dapsone |
49938-101 | Dapsone | Dapsone |
49938-102 | Dapsone | Dapsone |
51672-1387 | Dapsone | Dapsone |
51672-1388 | Dapsone | Dapsone |
51672-4197 | Dapsone | Dapsone |
68151-2693 | Dapsone | Dapsone |
69543-150 | Dapsone | Dapsone |
69543-151 | Dapsone | Dapsone |
70954-136 | DAPSONE | DAPSONE |
70954-135 | DAPSONE | DAPSONE |
51672-4198 | Dapsone | Dapsone |
55695-005 | Dapsone | Dapsone |
55695-025 | Dapsone | Dapsone |
60429-496 | Dapsone | Dapsone |
60429-495 | Dapsone | Dapsone |
60758-670 | DAPSONE | DAPSONE |
51672-5307 | Dapsone | Dapsone |
0023-3670 | ACZONE | dapsone |
0023-5206 | ACZONE | dapsone |
16110-367 | ACZONE | dapsone |
16110-526 | Aczone | dapsone |